论文部分内容阅读
目的探讨经尿道等离子体双极电切治疗前列腺增生(BPH)的安全性与有效性。方法用经尿道等离子体双极电切法行前列腺切除术(PKVP)81例。结果81例术中出血少,无前列腺电切综合征(TURS)和前列腺包膜穿孔发生。术后随访1-6个月,最大尿流率(Qmax)由术前的(6．2±4．1)ml／S上升至术后的(21．2±4．6)ml／S;国际前列腺症状评分(IPSS)由术前的(25．6±4.8)分下降至术后的(6．8±2．6)分;生活质量评分(QOL)由术前的(5．1±0．5)分降低至术后的(1．8±0．5)分;残余尿由术前的(67±70)ml减少至术后的(15±20)ml。结论经尿道等离子体双极电切治疗前列腺增生疗效确切,安全性好,并发症少。
Objective To investigate the safety and efficacy of transurethral plasma bipolar electrosurgical excision for benign prostatic hyperplasia (BPH). Methods Totally 81 cases underwent prostatectomy (PKVP) with transurethral plasma bipolar grafting. Results 81 cases of bleeding less, no prostate resection syndrome (TURS) and prostatic capsular perforation. The maximum flow rate (Qmax) increased from (6.2 ± 4.1) ml / S preoperatively to (21.2 ± 4.6) ml / S postoperatively for 1 to 6 months. The International Prostate Symptom Score (IPSS) decreased from (25.6 ± 4.8) points preoperatively to (6.8 ± 2.6) points postoperatively. The quality of life score (QOL) decreased from 5.1 ± 0.5) to (1.8 ± 0.5) points postoperatively; residual urine decreased from (67 ± 70) ml preoperatively to (15 ± 20) ml postoperatively. Conclusions Transurethral plasma bipolar grafting is effective in treating benign prostatic hyperplasia with good safety and few complications.